Home > Income Statement > MANGALAM DRUGS AND ORGANICS

MANGALAM DRUGS AND ORGANICS
Revenue

    Back to Income Statement
MANGALAM DRUGS AND ORGANICS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MANGALAM DRUGS AND ORGANICS
Please provide your vote to see the results

MANGALAM DRUGS AND ORGANICS Last 5 Year Revenue History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹372 Cr₹451 Cr₹385 Cr₹282 Cr₹228 Cr

What is the latest Revenue of MANGALAM DRUGS AND ORGANICS ?

The latest Revenue ratio of MANGALAM DRUGS AND ORGANICS is ₹372 Cr based on Mar2024 Standalone results.
Year Revenue
Mar2024₹372 Cr
Mar2023₹451 Cr
Mar2022₹385 Cr
Mar2021₹282 Cr
Mar2020₹228 Cr

How is Revenue of MANGALAM DRUGS AND ORGANICS Trending?

Years Revenue % Change
Mar2024 ₹372 Cr
-17.47
Mar2023 ₹451 Cr
17.25
Mar2022 ₹385 Cr
36.25
Mar2021 ₹282 Cr
24.07
Mar2020 ₹228 Cr -

Compare Revenue of peers of MANGALAM DRUGS AND ORGANICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS ₹161.1 Cr -11% -13.4% 3.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


MANGALAM DRUGS AND ORGANICS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANGALAM DRUGS AND ORGANICS

-11%

-13.4%

3.6%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses